Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-06
DOI
10.1038/s41598-017-02866-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Sinusoidal communication in liver fibrosis and regeneration
- (2016) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
- (2016) Federica Cerini et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
- (2016) Katherine Martin et al. Nature Communications
- Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy
- (2016) Diana Hide et al. Scientific Reports
- Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
- (2015) Sebastian Steven et al. BASIC RESEARCH IN CARDIOLOGY
- Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
- (2015) Paula L. McClean et al. BEHAVIOURAL BRAIN RESEARCH
- The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
- (2015) Huiting Gao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis
- (2015) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Hepatic fibrosis: Concept to treatment
- (2015) Christian Trautwein et al. JOURNAL OF HEPATOLOGY
- Effect of liraglutide on proliferation and differentiation of human adipose stem cells
- (2015) Giulia Cantini et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome
- (2015) Vanessa Hoang et al. PLoS One
- Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.
- (2015) Nan Lu et al. PLoS One
- A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury
- (2014) Diana Hide et al. CLINICAL SCIENCE
- GLP-1 Analog Liraglutide Enhances Proinsulin Processing in Pancreatic β-Cells via a PKA-Dependent Pathway
- (2014) Liang Wang et al. ENDOCRINOLOGY
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
- (2014) Giusi Marrone et al. GUT
- Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
- (2014) Xing-Chun Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Evolving therapies for liver fibrosis
- (2013) Detlef Schuppan et al. JOURNAL OF CLINICAL INVESTIGATION
- Precision-cut liver slices: A tool to model the liver ex vivo
- (2013) Peter Olinga et al. JOURNAL OF HEPATOLOGY
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway
- (2012) L. Laviola et al. ENDOCRINOLOGY
- Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans
- (2012) James Pritchett et al. HEPATOLOGY
- Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction
- (2012) Vincenzo La Mura et al. HEPATOLOGY
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
- (2012) T. Kisseleva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
- (2011) Guanhua Xie et al. GASTROENTEROLOGY
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
- (2010) Michael A. Nauck AMERICAN JOURNAL OF MEDICINE
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
- (2010) J. Gracia-Sancho et al. GUT
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Stellate Cell Contraction: Role, Regulation, and Potential Therapeutic Target
- (2008) Russell K. Soon et al. Clinics in Liver Disease
- Recent advances in the pathogenesis and diagnosis of liver fibrosis
- (2008) Natalie J. Török JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started